iron sucrose injection, USP
Drugiron sucrose injection, USP, 100 mg intravenously (IV) per week, for 5 weeks
NCT Number: NCT00534144
This study will compare the effects of sodium ferric gluconate complex and iron sucrose on urine concentrations of various chemicals including protein
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1
San Juan, Puerto Rico
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
iron sucrose injection, USP, 100 mg intravenously (IV) per week, for 5 weeks
sodium ferric gluconate complex in sucrose injection, 100 mg intravenously (IV) per week, for 5 weeks
Time frame: 6 weeks
Watson Pharmaceuticals
Industry
A Randomized Controlled Trial of the Effect of IV Iron on Proteinuria in Non-Dialysis Chronic Kidney Disease Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00224081
Anemia, Anemia, Hypochromic
Bakersfield, California, United States
View Trial DetailsNCT00354692
Anemia, Anemia, Hypochromic
Glendale, California, United States
View Trial DetailsNCT00224042
Anemia, Anemia, Hypochromic
Birmingham, Alabama, United States
View Trial DetailsNCT00224055
Anemia, Anemia, Hypochromic
Tucson, Arizona, United States
View Trial Details